Clinical and Molecular Hepatology10.3350/cmh.2022.03332023291113-117Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markersLilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip,,
Journal of Viral Hepatitis10.1111/jvh.138252023Hepatitis D virus infection: Progress on the path toward disease control and cureMark S. Sulkowski,
Journal of Viral Hepatitis10.1111/jvh.130812019266618-626New treatment options for delta virus: Is a cure in sight?Cihan Yurdaydin,,,
Journal of Viral Hepatitis10.1111/jvh.133062020279951-954Long‐term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients—Functional cure unlikelyJu‐Yeon Cho, Won Sohn, Yong‐Han Paik, Geum‐Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Chan Guk Park,,,
Journal of Hepatology10.1016/s0168-8278(88)80341-619887S143Hepatitis B virus DNA by in situ hybridization: Correlation between serum and hepatic markers of viral replication,
Journal of Viral Hepatitis10.1111/j.1365-2893.2007.00923.x200714s177-81Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis CS. Chevaliez, J.-M. Pawlotsky,
Journal of Viral Hepatitis10.1111/jvh.203_12923201825149-149P2-084: Predictive markers for hepatitis C virus infection among Brazilian inmates,
Journal of Viral Hepatitis10.1111/jvh.12333_120142121-22P2: Correlation of noninvasive serum fibrosis markers with stage of fibrosis in chronic hepatitis,,
Journal of Viral Hepatitis10.1111/jvh.126712017246486-495Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as preventionH. H. Ayoub, L. J. Abu-Raddad,
Journal of Viral Hepatitis10.1111/jvh.128232018254320-328The benefits of hepatitis C virus cure: Every rose has thornsD. Salmon, M. U. Mondelli, M. Maticic, J. E. Arends,,